Affiliated Hangzhou Hospital, Department of General Surgery, Nanjing Medical University, Hangzhou, China.
Braz J Med Biol Res. 2013 Aug;46(8):670-5. doi: 10.1590/1414-431X20133050. Epub 2013 Aug 13.
Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and homeostasis properties. We report here on the anticancer effect of ziyuglycoside II on human gastric carcinoma BGC-823 cells. We investigated the effects of ziyuglycoside II on cell growth, cell cycle, and cell apoptosis of this cell line. Our results revealed that ziyuglycoside II could inhibit the proliferation of BGC-823 cells by inducing apoptosis but not cell cycle arrest, which was associated with regulation of Bax/Bcl-2 expression, and activation of the caspase-3 pathway. Our study is the first to report the antitumor potential of ziyuglycoside II in BGC-823 gastric cancer cells. Ziyuglycoside II may become a potential therapeutic agent against gastric cancer in the future.
紫珠苷 II 是地榆的一种活性化合物,具有抗炎、抗氧化、抗菌和内稳态特性。我们在这里报告了紫珠苷 II 对人胃癌 BGC-823 细胞的抗癌作用。我们研究了紫珠苷 II 对该细胞系细胞生长、细胞周期和细胞凋亡的影响。结果表明,紫珠苷 II 通过诱导细胞凋亡而不是细胞周期阻滞来抑制 BGC-823 细胞的增殖,这与 Bax/Bcl-2 表达的调节和 caspase-3 途径的激活有关。我们的研究首次报道了紫珠苷 II 在 BGC-823 胃癌细胞中的抗肿瘤潜力。紫珠苷 II 将来可能成为治疗胃癌的一种潜在药物。